前收市價 | 18.67 |
開市 | 18.64 |
買盤 | 18.28 x 200 |
賣出價 | 18.32 x 200 |
今日波幅 | 18.27 - 18.95 |
52 週波幅 | 14.56 - 33.31 |
成交量 | |
平均成交量 | 1,277,125 |
市值 | 2.664B |
Beta 值 (5 年,每月) | 1.39 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.94 |
業績公佈日 | 2024年8月06日 - 2024年8月12日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 39.69 |
Denali (DNLI) Q1 loss narrows year over year due to lower expenses despite nil revenues.
Denali Therapeutics (DNLI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.